Turning Point Therapeutics Announces Scientific Advisory Board
SAN DIEGO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation […]
Usio Announces Appointment of Ernesto Beyer to its Board of Directors
SAN ANTONIO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq: USIO), an integrated electronic payment solutions provider, today announced […]
TSX News -
Titan Mining Announces Option to Earn up to 100% in the Mineral Ridge Gold Project in Nevada
VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI) (“Titan” or the “Company”) is pleased to […]
Latin Metals Acquires the Auquis Copper Property in Peru
VANCOUVER, British Columbia, Aug. 31, 2020 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) […]
H&R Block Adds Chief Product and Experience Officer and Chief Financial Services Officer to Its Senior Leadership Team
KANSAS CITY, Mo., Aug. 31, 2020 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) today announced that Julius Lai and Les […]
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
• Canadian government to purchase up to 76 million doses of NVX-CoV2373GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. […]
Vicon Releases Upgraded Thermal Sensor Models for Groundbreaking 360-Degree Surveillance
Hauppauge, NY, Aug. 31, 2020 (GLOBE NEWSWIRE) — — Vicon (www.vicon-security.com), a designer and manufacturer of video surveillance, access control […]
Odyssey CEO Mark Gordon to Deliver Keynote and Investor Presentation at The LD 500 Virtual Investor Conference August 31 and September 3
TAMPA, Fla., Aug. 31, 2020 (GLOBE NEWSWIRE) — Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a deep-ocean exploration pioneer engaged in the […]
LPL Financial Welcomes Summit Wealth Advisors
CHARLOTTE, N.C., Aug. 31, 2020 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA), a leading retail investment advisory firm, independent broker-dealer and […]
Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty […]
